Nuvalent Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVL | PTGX | KYMR | ||
| Company | Nuvalent Cl A | Protagonist Therapeutics Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 123.97 | 148.21 | 110.22 | ||
| High | 123.99 | 152.70 | 115.00 | ||
| Low | 123.95 | 147.33 | 109.08 | ||
| Last | 123.96 | 152.01 | 114.03 | ||
| Change | +0.02 | +3.72 | +4.41 | ||
| Percent Change | +0.02% | +2.51% | +4.02% | ||
| Volume | 3,085,800 | 417,200 | 961,000 | ||
| 20-Day Average Volume | 2,194,735 | 519,390 | 664,475 | ||
| Previous | 123.94 | 148.29 | 109.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 123.61 | 139.05 | 108.68 | ||
| 20-Day Raw Stochastic | 96.00% | 96.87% | 71.44% | ||
| 20-Day Relative Strength | 64.35 | 66.58 | 59.58 | ||
| Weighted Alpha | +28.91 | +154.13 | +130.17 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 96% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 07/07/26 | +10.70% since 08/05/26 | +8.11% since 08/05/26 | ||
| Low | 123.73 on 07/08/26 | 139.95 on 08/06/26 | 103.37 on 08/06/26 | ||
| High | 123.99 on 07/14/26 | 152.70 on 08/12/26 | 115.00 on 08/12/26 | ||
| 1-Month | |||||
| %Chg | +0.58% since 06/12/26 | +15.67% since 07/10/26 | -4.46% since 07/10/26 | ||
| Low | 123.24 on 06/15/26 | 125.32 on 07/13/26 | 99.52 on 08/03/26 | ||
| High | 123.99 on 07/14/26 | 152.70 on 08/12/26 | 119.83 on 07/20/26 | ||
| 3-Month | |||||
| %Chg | +18.03% since 04/14/26 | +52.09% since 05/12/26 | +36.48% since 05/12/26 | ||
| Low | 87.30 on 06/08/26 | 92.75 on 06/02/26 | 69.48 on 06/03/26 | ||
| High | 123.99 on 07/14/26 | 152.70 on 08/12/26 | 130.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +14.95% since 01/14/26 | +85.54% since 02/12/26 | +35.72% since 02/12/26 | ||
| Low | 87.30 on 06/08/26 | 77.00 on 02/23/26 | 69.48 on 06/03/26 | ||
| High | 123.99 on 07/14/26 | 152.70 on 08/12/26 | 130.05 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,792,592 | 9,836,262 | 9,481,709 | ||
| Shares Outstanding, K | 78,998 | 64,708 | 83,151 | ||
| Annual Sales, $M | 0 | 46,020,000 | 39,210,000 | ||
| Annual Net Income, $M | -425,380,000 | -130,150,000 | -311,350,000 | ||
| Last Qtr Sales, $M | 0 | 213,480,000 | 65,000,000 | ||
| Last Qtr Income, $M | -109,280,000 | 162,850,000 | -61,210,000 | ||
| 60-Month Beta | 1.14 | 1.78 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.39 on 05/07/26 | 2.29 on 08/05/26 | -0.62 on 08/05/26 | ||
| Latest Earnings Date | 08/06/26 | 11/05/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 143.97 | 0.00 | ||